Skip to main content

Amneal to Participate at Upcoming Investor Conference

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 2024 Jefferies Healthcare Conference on June 5, 2024.

Chirag will present at 1:30 PM EST. A live webcast of the presentation will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.21
+2.26 (1.04%)
AAPL  260.49
+2.04 (0.79%)
AMD  234.09
+3.87 (1.68%)
BAC  51.60
+0.50 (0.99%)
GOOG  255.25
+2.72 (1.08%)
META  740.09
+6.68 (0.91%)
MSFT  523.30
+2.76 (0.53%)
NVDA  182.12
+1.84 (1.02%)
ORCL  280.80
+8.14 (2.99%)
TSLA  435.03
-3.94 (-0.90%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.